© 2020 MJH Life Sciences and OncLive. All rights reserved.
February 21, 2020
Andrea Cercek, MD, discusses targeted strategies in BRAF-mutant metastatic colorectal cancer.
February 19, 2020
Andrea Cercek, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the impact of tumor sidedness on frontline treatment decisions in metastatic colorectal cancer (mCRC).
February 11, 2020
Andrea Cercek, MD, discusses the need for treatment options in KRAS-mutated metastatic colorectal cancer (mCRC).
February 08, 2020
Andrea Cercek, MD, discusses the importance of molecular testing in colorectal cancer.